Susan Galbraith logo AstraZeneca logo

Susan Galbraith

Senior Vice-President IMED Oncology, AstraZeneca, Cambridge, UK


Susan Galbraith is Head of the IMED Oncology, responsible for Oncology discovery and early development, to Proof of Concept.
A UK trained Clinical Oncologist with a PhD in Oncology - Vascular Targeting Agents - endothelial cell shape change effects and translational dynamic MRI to measure effects on tumor microcirculation.
Specialised in Oncology early drug development and Biomarker development.

Susan Galbraith logo

Susan Galbraith

Senior Vice-President IMED Oncology, AstraZeneca, Cambridge, UK


AstraZeneca logo

Susan Galbraith is Head of the IMED Oncology, responsible for Oncology discovery and early development, to Proof of Concept.
A UK trained Clinical Oncologist with a PhD in Oncology - Vascular Targeting Agents - endothelial cell shape change effects and translational dynamic MRI to measure effects on tumor microcirculation.
Specialised in Oncology early drug development and Biomarker development.


Why WIN